Skip to main content
Figure 3 | Molecular Autism

Figure 3

From: Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects

Figure 3

Decrease in ERβ and CYP19A1 protein levels in the middle frontal gyrus of ASD subjects. ERα, ERβ, and CYP19A1 protein levels were determined by western blot analysis. The upper panels show representative autoradiogram of ( A ) ERα, ( B ) ERβ, or ( C ) CYP19A1 and GAPDH, and the lower panels represent fold-change in normalized ERα, ERβ, and CYP19A1 protein levels, respectively. Results are mean ± SEM vs. controls. *P <0.05 vs. controls.

Back to article page